Filtros de búsqueda

Lista de obras de Ariadna Tibau

Assessment of Frequency and Reporting of Changes in Cancer Trial Design After Initiation of Patient Accrual

artículo científico publicado en 2019

Assessment of frequency and reporting of design changes among clinical drug trials published in influential medical journals

scientific article published on 19 August 2019

Association Between Data Sources and US Food and Drug Administration Drug Safety Communications

scientific article published on 03 September 2019

Author financial conflicts of interest, industry funding, and clinical practice guidelines for anticancer drugs

artículo científico publicado en 2014

Clinical benefit and cost of breakthrough cancer drugs approved by the US Food and Drug Administration

artículo científico publicado en 2020

Extended adjuvant tamoxifen for early breast cancer: a meta-analysis.

artículo científico publicado en 2014

Impact of Availability of Companion Diagnostics on the Clinical Development of Anticancer Drugs

artículo científico publicado en 2017

Interaction between Hormonal Receptor Status, Age and Survival in Patients with BRCA1/2 Germline Mutations: A Systematic Review and Meta-Regression

artículo científico publicado en 2016

Magnitude of Clinical Benefit of Cancer Drugs Approved by the US Food and Drug Administration Based on Single-Arm Trials

scientific article published on 01 November 2018

Magnitude of Clinical Benefit of Cancer Drugs Approved by the US Food and Drug Administration.

artículo científico publicado en 2017

Oncologic Drugs Advisory Committee Recommendations and Approval of Cancer Drugs by the US Food and Drug Administration.

artículo científico publicado en 2016

Patient-Centered Cancer Drug Development: Clinical Trials, Regulatory Approval, and Value Assessment

artículo científico publicado en 2019

Postmarketing Modifications of Drug Labels for Cancer Drugs Approved by the US Food and Drug Administration Between 2006 and 2016 With and Without Supporting Randomized Controlled Trials.

artículo científico publicado en 2018

Postmarketing Safety-Related Modifications of Drugs Approved by the US Food and Drug Administration Between 1999 and 2014 Without Randomized Controlled Trials

artículo científico publicado en 2019

Prices and clinical benefit of cancer drugs in the USA and Europe: a cost-benefit analysis

scientific article published on 01 May 2020

Raising concern about the American Society of Clinical Oncology conflict of interest policy amendment

artículo científico publicado en 2014

Response

artículo científico publicado en 2018

Role of cooperative groups and funding source in clinical trials supporting guidelines for systemic therapy of breast cancer.

artículo científico publicado en 2018

Safety-Related Postmarketing Modifications of Drugs for Hematological Malignancies

artículo científico publicado en 2019

Undisclosed financial conflicts of interest among authors of American Society of Clinical Oncology clinical practice guidelines

scientific article published on 29 July 2019

Dominio Público Uruguay está sostenido por:

Acerca de Dominio Público Uruguay

Ayuda